Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer
Stopped early · Not applicable
Conditions studied: Cervical Cancer
In brief
This study is to assess how patients respond to their treatment for cervical cancer. This research does not involve a specific treatment for the cancer that will be recommended by the doctor and may include radiation therapy and/or chemotherapy. This is a separate research imaging study designed to assess how patients respond to their treatment for cervical cancer.
Key facts
- Study ID
- NCT01613521
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 3
- Starts
- 2012-06-01
- Expected to finish
- 2014-03-01
- Last updated by the study team
- 2014-03-13
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Biopsy-documented, newly-diagnosed primary cervical cancer of all histopathology types.
- Clinically visible gross lesion (International Federation of Gynecology and Obstetrics (FIGO) stage IB1 and above).
- Treatment (chemoradiation), DCE-MRI and 18F-FMISO PET studies will be at MSKCC.
- Patients must be an adult female 18 years of age or older.
You may not qualify if…
- Patients who because of general medical or psychiatric condition, or physiologic status cannot give an informed consent.
- Patients who received prior radiation treatment to pelvis.
- Patients with contraindications to DCE-MRI (non-compatible cardiac pacemakers or intracranial vascular clips, allergy to Gadolinium, end-stage renal disease) and/or 18F-FMISO PET.
- Patients who do not fulfill the screening criteria for safe DCE-MRI or 18F-FMISO PET as per the Department of Radiology guidelines.
- Pregnant patients; and or patients who are breast-feeding their babies.
Where it is running
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.